Transforming growth factor-α attenuates hepatic fibrosis: possible involvement of matrix metalloproteinase-1
Transforming growth factor-α attenuates hepatic fibrosis: possible involvement of matrix metalloproteinase-1
复制标题
DOI:
10.1111/j.1478-3231.2011.02475.x
复制
发表时间:
2011-04-01
影响因子:
6.7
通讯作者:
Mori, Masatomo
中科院分区:
文献类型:
--
作者:
Ohyama, Tatsuya;Yamazaki, Yuichi;Mori, Masatomo
Background: The effect of transforming growth factor (TGF)-alpha on fibrosis varies between cell types and the role of TGF-alpha in hepatic fibrosis has not been fully elucidated. Methods: We examined the effect of TGF-alpha on hepatic fibrosis using TGF-alpha-expressing transgenic mice fed a methionine- and choline-deficient (MCD) diet and human hepatic stellate cells (HSCs) line LX-2, rat and human primary HSCs. Results: Although the expression levels of the tissue inhibitor of metalloproteinases-1 and alpha 1(I) collagen mRNA were unchanged, feeding the TGF-alpha transgenic mice the MCD diet resulted in greater expression of the murine functional analogue of matrix metalloproteinase-1 (MMP-1), MMP-13 mRNA and protein and attenuated hepatic fibrosis compared with wild-type mice. TGF-alpha overexpression did not affect the extent of the steatosis, oxidative stress and hepatic inflammation in the MCD diet-fed mice. The effect of TGF-alpha on the fibrogenic and anti-fibrogenic gene expressions varied between cell types in vitro. TGF-alpha increased MMP-1 mRNA expressions that were completely blocked by gefitinib in LX-2 cells. The extracellular signal-regulated kinase (ERK) 1/2, c-Jun N-terminal kinase and p38 pathways were involved in MMP-1 mRNA expression in LX-2 cells. Although TGF-alpha increased the phosphorylation of p38, the p38 inhibitor activated the RAS- ERK pathway and increased TGF-alpha-induced MMP-1 mRNA expression, which suggested that there may be a crosstalk between the RAS- ERK and the p38 pathways in LX-2 cells. Conclusions: The TGF-alpha may attenuate hepatic fibrosis in part because of upregulation of the expression of MMP-1. The balance between fibrogenic and anti-fibrogenic gene expression and between the activity of the RAS- ERK and the p38 pathways may be crucial for the fibrotic process.